AIM ImmunoTech appoints David Chemerow as independent director; reduces stockholder meeting quorum to 33 1/3%

AIM ImmunoTech Inc.

David Chemerow appointed as independent director, effective February 24, 2025.
Chemerow brings 40+ years of finance, accounting, and operations leadership experience; former CFO of Comscore.
Bylaws amended to reduce quorum for stockholder meetings from 40% to 33 1/3%.
Chemerow will be compensated same as other directors; serves until 2025 Annual Meeting.

item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David I. Chemerow

Director

AIM · AIM ImmunoTech Inc.

Effective: 2025-02-24
Filed: February 26, 2025, 6:59 PM ET

On February 26, 2025, AIM ImmunoTech Inc. (the "Company") issued a press release announcing the appointment of David I. Chemerow to its Board of Directors (the "Board"), effective February 24, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David I. Chemerow was appointed as Director at AIM ImmunoTech Inc..

Action: appointed
Role: Director

Exact text from the filing

On February 26, 2025, AIM ImmunoTech Inc. (the "Company") issued a press release announcing the appointment of David I. Chemerow to its Board of Directors (the "Board"), effective February 24, 2025

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

AIM ImmunoTech Inc.: Reduced quorum for stockholder meetings from 40% to 33 1/3% (effective 2025-02-24).

Change: bylaw amendment
Effective: 2025-02-24

Exact text from the filing

On February 24, 2025, the Company adopted Restated and Amended Bylaws. The Restated and Amended Bylaws revise Section 1.6 Quorum, reducing the quorum for stockholder meetings from 40% to 33 and 1/3%.

View on SEC.gov

188 governance changes filed in the last 30 days. Browse all governance changes →

AIM ImmunoTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-008282

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.